Transcriptomics

Dataset Information

0

Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming


ABSTRACT: To study the impacts of glycolytic states of tumor cells, we took advantage of different in vitro culture systems and established demanded glycolysis states in B16F10 cells. B16F10 cells were maintained with either RPMI-1640 or DMEM mediums to maintain different metabolic models.

ORGANISM(S): Mus musculus

PROVIDER: GSE233834 | GEO | 2023/07/07

REPOSITORIES: GEO

Similar Datasets

2019-06-04 | GSE132119 | GEO
2015-06-17 | GSE61670 | GEO
2019-06-01 | GSE130910 | GEO
2015-06-17 | E-GEOD-61670 | biostudies-arrayexpress
2009-12-31 | GSE19704 | GEO
2019-04-18 | PXD013127 | Pride
2018-12-22 | GSE124291 | GEO
2009-10-01 | GSE13102 | GEO
2023-08-06 | GSE210767 | GEO
2022-01-19 | ST002061 | MetabolomicsWorkbench